Search by Drug Name or NDC
NDC 00067-8139-02 Excedrin 500; 65 mg/1; mg/1 Details
Excedrin 500; 65 mg/1; mg/1
Excedrin is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; CAFFEINE.
Product Information
| NDC | 00067-8139 |
|---|---|
| Product ID | 0067-8139_5e057926-8baf-4283-ae59-91130e8ea0ca |
| Associated GPIs | |
| GCN Sequence Number | 013760 |
| GCN Sequence Number Description | acetaminophen/caffeine TABLET 500MG-65MG ORAL |
| HIC3 | H3E |
| HIC3 Description | ANALGESIC/ANTIPYRETICS,NON-SALICYLATE |
| GCN | 72555 |
| HICL Sequence Number | 001855 |
| HICL Sequence Number Description | ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Brand |
| Proprietary Name | Excedrin |
| Proprietary Name Suffix | Tension Headache |
| Non-Proprietary Name | Acetaminophen, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 500; 65 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; CAFFEINE |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00067-8139-02 (00067813902)
| NDC Package Code | 0067-8139-02 |
|---|---|
| Billing NDC | 00067813902 |
| Package | 1 BOTTLE in 1 CARTON (0067-8139-02) / 100 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2016-12-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |